PPARG and Insulin resistance: It is known that MAPKs and NF-κB, activated by tumor necrosis factor-α (TNF-α), reduce insulin signaling, arouse inflammatory responses and interfere with peroxisome proliferator-activated receptor gamma (PPAR-γ) activity, leading to insulin resistance and adipose dysfunction [20].